EUCRU

Eucrates Biomedical Acquisition Corp. Unit
EUCRU

Delisted

EUCRU was delisted on the 26th of April, 2023.

Back to rankings

6 hedge funds and large institutions have $6.51M invested in Eucrates Biomedical Acquisition Corp. Unit in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 9 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
6
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$26K
2
+$3.94K

Top Sellers

1
-$1.31M
2
-$1M
3
-$794K
4
SIA
Schechter Investment Advisors
Michigan
-$792K
5
RCM
Rivernorth Capital Management
Florida
-$758K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$3.97M
2
$2.48M
3
$26.3K
4
$26K
5
$3.94K
6
$10
7
–
8
–
9
–
10
–
11
–
12
–
13
–
14
–